{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:04:19Z","timestamp":1792839859981,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T00:00:00Z","timestamp":1704585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021981","name":"Roche Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021981","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.msard.2024.105434","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T15:38:31Z","timestamp":1705160311000},"page":"105434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Predicting time to serologic diagnosis of AQP4+ NMOSD based on clinical factors and social determinants of health"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7280-3684","authenticated-orcid":false,"given":"Dalia L.","family":"Rotstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesly","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"McCombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Konig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manav V.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2024.105434_bib0001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105434_bib0002","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jamaneurol.2021.3416","article-title":"Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: a review","volume":"78","author":"Amezcua","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2024.105434_bib0004","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1212\/NXI.0000000000000468","article-title":"Mortality in neuromyelitis optica is strongly associated with African ancestry","volume":"5","author":"Mealy","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2024.105434_bib0005","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awz054","article-title":"Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders","volume":"142","author":"Palace","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.msard.2024.105434_bib0007","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","article-title":"Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: diagnosis and differential diagnosis","volume":"270","author":"Jarius","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2024.105434_bib0008","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/13524585231179108","article-title":"Rectifying global inequities in neuromyelitis optica diagnosis and treatment","volume":"29","author":"Mateen","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105434_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104498","article-title":"Factors associated with the misdiagnosis of neuromyelitis optica spectrum disorder","volume":"70","author":"Smith","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105434_bib0010","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1212\/NXI.0000000000000580","article-title":"Neuromyelitis optica spectrum disorder: patient experience and quality of life","volume":"6","author":"Beekman","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2024.105434_bib0011","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.msard.2017.07.014","article-title":"Patient perspectives on neuromyelitis optica spectrum disorders: data from the PatientsLikeMe online community","volume":"17","author":"Eaneff","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105434_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.966428","article-title":"The patient journey with NMOSD: from initial diagnosis to chronic condition","volume":"13","author":"Delgado-Garcia","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2024.105434_bib0013","doi-asserted-by":"crossref","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica spectrum disorder","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105434_bib0014","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1212\/NXI.0000000000000225","article-title":"Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus","volume":"3","author":"Sepulveda","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2024.105434_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.socscimed.2014.03.022","article-title":"Incorporating intersectionality theory into population health research methodology: challenges and the potential to advance health equity","volume":"110","author":"Bauer","year":"2014","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.msard.2024.105434_bib0016","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1177\/13524585231185046","article-title":"Social determinants of health and disparate disability accumulation in a cohort of black, hispanic, and white patients with multiple sclerosis","volume":"29","author":"Orlando","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105434_bib0017","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1093\/brain\/awab342","article-title":"Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis","volume":"144","author":"Vasileiou","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.msard.2024.105434_bib0018","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/1352458519887328","article-title":"Race and ethnicity on MS presentation and disease course","volume":"26","author":"Amezcua","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105434_bib0019","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41582-022-00735-5","article-title":"Social determinants of health in multiple sclerosis","volume":"18","author":"Dobson","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2024.105434_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102641","article-title":"Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: subgroup analyses of the randomized controlled phase 3 PREVENT trial","volume":"47","author":"Palace","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105434_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jnnp-2021-327206","article-title":"Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders","volume":"93","author":"Camera","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.msard.2024.105434_bib0021","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1177\/1352458521988926","article-title":"Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD","volume":"27","author":"Cree","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105434_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104485","article-title":"Barriers to access and unmet needs to neuromyelitis optica spectrum disorders care in an Argentinean cohort","volume":"70","author":"Tkachuk","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105434_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104114","article-title":"Risk factors associated with permanent disability in neuromyelitis optica spectrum disorders","volume":"68","author":"Valdivia-Tangarife","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105434_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103716","article-title":"A point-of-care diagnostic test for aquaporin-4 antibody seropositive neuromyelitis optica","volume":"60","author":"Rice","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105434_bib0006","unstructured":"Statistics Canada. Census Profile, 2021 Census of the Population. [online]. Available at: https:\/\/www12.statcan.gc.ca\/census-recensement\/2021\/dp-pd\/prof\/index.cfm?Lang=E. Accessed May 10, 2023."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:28:41Z","timestamp":1778840921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":24,"alternative-id":["S2211034824000130"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105434","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting time to serologic diagnosis of AQP4+ NMOSD based on clinical factors and social determinants of health","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105434"}}